Four INVO shares will become one on Oct. 30. Registered holders get a whole share; broker-held fractions are paid in cash.
INVO Fertility (NASDAQ: IVF) announced a 1-for-4 reverse stock split effective October 30, 2026. Registered holders will receive whole shares, while fractional shares held via brokers will be paid in cash. Post-split, the company will have approximately 1.19 million shares outstanding. The stock will continue trading under the symbol 'IVF'.
How this was made
The 30-second read
Why it matters
The reverse split reduces share count to ~1.19 M, adjusts authorized shares to 62.5 M, and may improve liquidity and market perception.
Market read
A corporate action that could modestly affect IVF's share price and trading dynamics; relevant for short‑term traders and position managers.
What to watch
Potential dilution from future capital raises or acquisition activity could offset any price benefit from the split.
Background
INVO Fertility (NASDAQ: IVF) focuses on fertility clinics and the INVOcell technology. The company has four U.S. clinics and is expanding its platform.
Ticker impact
INVO Fertility announced a 1-for-4 reverse stock split effective Oct. 30, 2026, changing share count and cashing fractional shares.
potential upward pressure as the market prices in the higher post‑split share price.
Reverse splits are typically viewed as a neutral to mildly positive catalyst for thinly traded stocks, especially when accompanied by a cash payment for fractions.
Market effects
May signal consolidation in the fertility‑clinic sector, prompting peers to consider similar actions.
Limited to U.S. listed biotech/healthcare micro‑caps.
Low; primarily affects INVO and its immediate investors.
Counterpoint
Some investors may view the split as a red flag of underlying weakness and short the stock.
Key entities
- companyINVO Fertility, Inc.
Healthcare services fertility company executing the reverse split.
- executiveSteve Shum
CEO of INVO Fertility, quoted in the release.
